Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Agnosia 8 Pain 7 Breast Neoplasms 5 Pain, Postoperative 3 Cancer Pain 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Postoperative Nausea and Vomiting 1 Postoperative Cognitive Complications 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Chronic Pain 1

Interventions

Morphine 7 Surveys and Questionnaires 6 Ketamine 5 Fentanyl 4 Sodium Chloride 3 Saline Solution 3 Lidocaine 3 Educational Status 3 Dexmedetomidine 3 Cognitive Behavioral Therapy 3 Anesthetics, Local 3 ziconotide 2 Pregabalin 2 Mindfulness-Based Stress Reduction 2 Hypnosis 2 Control Groups 2 Bupivacaine 2 Botulinum Toxins, Type A 2 Acetaminophen 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 tianeptine 1 siltuximab 1 onabotulinum toxin A 1 nabiximols 1 morphine, naltrexone combination 1 erenumab 1 Yoga 1 Waiting Lists 1 Transcutaneous Electric Nerve Stimulation 1 Tramadol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chronic Pain × Analgesics, Opioid × Clear all

NCT01541124 2018-02-08

Morphine as First Drug for Cancer Pain

Federal University of São Paulo

Phase NA Completed

Cancer Pain, Agnosia, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡